1256PCombined ipilimumab and nivolumab first-line and after BRAF-directed targeted therapies in advanced melanoma patients
Dearden, H C, Mason, R, Nguyen, B, Soon, J A, Smith, J L, Randhawa, M, Mant, A, Warburton, L, Lo, S, Meniawy, T, Guminski, A, Parente, P, Ali, S, Haydon, A, Long, G V, Carlino, M S, Millward, M, AtkinVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy289.012
Date:
October, 2018
File:
PDF, 77 KB
english, 2018